Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic
Sahu, Kamal Kant Siddiqui, Ahmad Daniyal Rezaei, Nima Cerny, Jan
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
It is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.
Source
Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251. Epub ahead of print. PMID: 32619062. Link to article on publisher's site